Renal Cancer - Results from #7660

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors - Abstract June 5, 2013

Fenoldopam and renal function after partial nephrectomy in a solitary kidney: A randomized, blinded trial - Abstract June 4, 2013

The imaging and pathological features of a mucinous tubular and spindle cell carcinoma of the kidney: A case report - Abstract June 4, 2013

Low-grade clear cell renal cell carcinoma mimicking hemangioma of the kidney: A series of 4 cases - Abstract June 4, 2013

Advanced native kidney renal cell carcinoma in renal transplant recipients: Role of sirolimus as dual anti-cancer and anti-rejection agent - Abstract June 4, 2013

Metastasis of renal cell carcinoma to the bladder - Abstract May 31, 2013

Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC) - Abstract May 31, 2013

Axitinib for the treatment of metastatic renal cell carcinoma: Recommendations for therapy management to optimize outcomes - Abstract May 31, 2013

Metastatic renal cell carcinoma to the thyroid gland 24 years after the primary tumour - Abstract May 31, 2013

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium - Abstract May 31, 2013

Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma - Abstract May 31, 2013

A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis - Abstract May 29, 2013

A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinoma - Abstract May 29, 2013

Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable - Abstract May 29, 2013

Two cases of bowel perforation in patients with metastatic renal cancer treated with molecular target drug - Abstract May 28, 2013

Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma - Abstract May 28, 2013

Robot-assisted partial nephrectomy in contemporary practice - Abstract May 28, 2013

Optimal management of metastatic renal cell carcinoma: Current status - Abstract May 27, 2013

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: An analysis of the multicenter CORONA database - Abstract May 27, 2013

Zoledronic acid in genitourinary cancer - Abstract May 27, 2013

Page 384 of 455